what is precision medicine in lung cancer? Dr prasanna rammohan MD DM ECMO FCPM senior oncologist gold medalist medical director cancure cancer centre trichy shares his expert insights on precision medicine in lung cancer. Non small cell lung cancer is often driven by druggable targeted genetic mutation which can be tested using NGS molecular biomarker testing. Most common druggable target is EGFR gene mutation which can be targeted with oral EGFR tyrosine kinase inhibitors yielding high response rates and median survival rates in advanced lung cancer. Cancure cancer centre trichy offers NGS testing for lung cancer and employs precision targeted drugs for advanced lung cancer with best clinical outcomes. Get in touch with us to know more about lung cancer biomarkers and personalised medicine.